AI assistant
STRIDES PHARMA SCIENCE LIMITED — Board/Management Information 2024
Jul 30, 2024
62616_rns_2024-07-30_2314e054-fec9-4a51-ab45-73a2030cfd24.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [144 x 47] intentionally omitted <==
July 30, 2024
The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.
Scrip Code: STAR
The BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001.
Scrip Code: 532531
Dear Sirs,
Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations)
Reg: Completion of tenure of Mr. S Sridhar as Independent Director of the Company
We hereby inform you that Mr. S Sridhar has completed his tenure as Independent Director of the Company with effect from closing business hours of July 30, 2024.
Mr. Sridhar is associated with Strides since July 2012. He was part of the Audit Committee since his appointment and as Chairperson of the Audit Committee since May 2014. Sridhar has also been a member of other Board Committees at Strides. His rich experience in the financial services sector and expertise in the fields of banking and finance has immensely benefited the Company.
Board of Directors of the Company place on record their sincere appreciation for the valuable contributions made by Sridhar during his association with Strides.
Disclosure pursuant to Regulation 30 of SEBI Listing Regulations read with SEBI Circular of July 13, 2023, in relation to the above is enclosed as an Annexure.
The above information will also be available on website of the Company at www.strides.com.
This is for your kind information and record purpose.
Thanks & Regards, For Strides Pharma Science Limited,
MANJULA R
Digitally signed by MANJULA R Date: 2024.07.30 18:27:36 +05'30'
Manjula Ramamurthy Company Secretary ICSI Membership No. A30515
Encl. as above
==> picture [472 x 48] intentionally omitted <==
Annexure
==> picture [144 x 47] intentionally omitted <==
Disclosure pursuant to Regulation 30 of SEBI Listing Regulation read with SEBI Circular SEBI/ HO/ CFD/ CFD-PoD-1/ P/ CIR/ 2023/ 123 dated July 13, 2023
Completion of tenure of Mr. S Sridhar (DIN: 00004272) as Independent Director of the Company
| # | Details | Information of such event | ||
|---|---|---|---|---|
| 1. | Reasons for change,~~viz., appointment,~~ ~~resignation, removal, death~~or otherwise |
Mr. S Sridhar (DIN: 00004272) has completed his second and final term as Independent Director of the Company with effect from closing business hours of July 29, 2024. |
||
| 2. | Date of~~appointment/ re-appointment/~~ cessation~~and term of appointment/ re-~~ ~~appointment~~ |
|||
| 3. | Brief profile (in case of appointment) | Not Applicable | ||
| 4. | Disclosure of relationships between directors (in case of appointment of a director) |
|||
| 5. | Disclosure of relationship between directors (in case of appointment of a director) |
==> picture [472 x 48] intentionally omitted <==